Antimicrobials are substance that kills microorganisms such as bacteria or mold, or stops them from growing and causing disease.
Triosyn Corp., a developer of products aimed at protecting against microbial threats, announced today that tests conducted by Health Canada’s National Microbiology Laboratory show that Triosyn T-1000™ Series Respirators protect against Severe Acute Respiratory Syndrome (SARS).
Methicillin resistant Staphylococcus aureus (MRSA) is a virulent organism, essentially resistant to all beta-lactam antibiotics (for example: penicillins, ampicillins, cephalosporins). It can cause skin, bone and life-threatening blood infections, as well as pneumonia.
New findings about a protein that keeps cells alive by opening and closing pores within a cell's membrane may open the door to the development of new antibiotics.
Viruses’ growing resistance to drugs means diseases such as hepatitis B and C are increasingly difficult to treat. New pandemics may arise with unforeseeable consequences.
The study, published in The Journal of Infectious Diseases, is the first to show a link between respiratory syncytial virus, or RSV, infection and asthma in mice. A related study, also in mice, suggests that a medication neutralizing the virus could decrease children's chances of developing asthma.
Doing laundry using hot water and bleach may prevent infections in the home, while drinking only bottled water may promote infections, according to research.
Results from an ongoing surveillance study, PROTEKT US (Prospective Resistant Organism Tracking and Epidemiology of the Ketolide Telithromycin – United States) Year 2 (2001-2002), suggest that KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates, including those resistant to other antimicrobial agents.
The addition of zinc to standard antimicrobial treatment may accelerate recovery from pneumonia, say researchers in this week's issue of The Lancet.
The Centers for Disease Control and Prevention (CDC) is spotlighting an educational campaign to help long-term care medical directors and clinicians prevent antimicrobial resistance and protect the health of their residents.
Patients with chronic inflammatory disorders, including infections, inflammatory bowel disease, arthritis and cancer, commonly become anemic. The anemia can make them sicker, is sometimes severe enough to require a blood transfusion, and responds only partially to current treatments.
Johnson & Johnson Wound Management today announced the introduction of SILVERCEL™ antimicrobial alginate dressing, providing the protection of silver and the absorption of alginate.